Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
EndoTex NexStent, Filter Wire EZ · 1 trial · 3 indications
| Arm | Type | Description |
|---|---|---|
| 1 | EXPERIMENTAL | - |
| Name | Type | Description |
|---|---|---|
| EndoTex™ NexStent™ | DEVICE | EndoTex™ NexStent™ is a flexible, fine mesh Nitinol stent used to treat patients that are at high risk of adverse events from carotid endarterectomy and require carotid revascularization of a target vessel that has a reference diameter between 4mm and 9mm and stenosis that is less than 30mm in length. |
| Filter Wire EZ™ | DEVICE | EPI Fliter Wire EZ™ Embolic Protection System is indicated for use as a guide wire and embolic protection system to contain and remove embolic material (thrombus/debris) while performing angioplasty and stenting procedures in coronary saphenous vein bypass grafts and carotid arteries. |
Inclusion Criteria: * patient is greater than or equal to 18 years of age. * Anticipated patient life expectancy is of at least one year from the date of the index procedure. * Lesion is located in the common carotid artery (CCA) and/or the internal carotid artery (ICA) or the carotid bifurcation. ...
EndoTex NexStent, Filter Wire EZ is used for carotid artery revascularization in patients with transient ischemic attack, thromboembolic stroke, and for stroke prevention. It is an investigational device being studied in a Phase 3 clinical trial.
EndoTex NexStent, Filter Wire EZ is developed by Boston Scientific Corporation, which trades under the ticker BSX. The company is conducting a Phase 3 clinical trial to evaluate the device for carotid artery revascularization.
EndoTex NexStent, Filter Wire EZ is in Phase 3 clinical development. It is an investigational device and has not been approved by the FDA. One Phase 3 trial has been completed.
EndoTex NexStent, Filter Wire EZ is studied in clinical trial NCT00600327, titled 'Carotid Artery Revascularization Using the Boston Scientific EPI Filter Wire EZ™ and the EndoTex™ NexStent™'. This Phase 3 trial enrolled 488 participants and is completed.
EndoTex NexStent, Filter Wire EZ is a combination device that includes the Filter Wire EZ. The clinical trial evaluates both the EndoTex NexStent and the Filter Wire EZ together for carotid artery revascularization.